January 28, 2009 - Philips is leading a major new European project, the SonoDrugs project, which uses focused ultrasound pulses and magnetic resonance imaging (MRI) to deliver and track therapeutic drugs used to treat cancer and cardiovascular disease, in hopes of maximizing efficiency and minimizing side effects.

January 28, 2009 - Australian-based Pro Medicus Limited said today it has acquired Visage Imaging, a digital imaging and advanced 3D visualization technology based in Carlsbad, CA.

January 28, 2009 - Attended by over 40 cardiothoracic surgeons, Cardiogenesis Corp.'s education symposium at the recent Society of Thoracic Surgeons Meeting in San Francisco was entitled "Advancements in Revascularization & Stem Cell Therapy."

January 28, 2009 - Boston Scientific Corp. and Medtronic Inc. today announced the settlement of two lawsuits and an agreement to stand down in three others.

These agreements stop all current litigation between the two parties in the fields of interventional cardiology and endovascular repair. All the disputes involved intellectual property.

January 28, 2009 – Under the terms of a newly penned seven-year agreement, LeMaitre Vascular has earned exclusive rights to market and sell certain sizes of Neovasc Inc.’s biological vascular strip for use in vascular surgery procedures in the U.S. and Europe.

January 28, 2009 - SurModics Inc. and Nexeon MedSystems Inc. this week signed a licensing agreement to collaborate on development of a novel stent system for the treatment of renal artery disease.

This agreement is in addition to the prior one announced in July 2007 to develop a novel stent system for coronary artery disease, which is now in clinical trials. SurModics is also an equity investor in Nexeon MedSystems.

January 28, 2009 - The AF Summit returns this year during Heart Rhythm 2009, set for May 13-16 in Boston, after a sold-out event at Heart Rhythm 2007.

This one-and-a-half-day summit will highlight the latest advances in atrial fibrillation and including a jointly sponsored session with the American Association for Thoracic Surgery (AATS).

The sessions on Wednesday, May 13 will cover pushing the envelope of scientific and personal discovery, ablative intervention in 2010, ablation vs. surgery for AF and a keynote by Dr. J. Craig Venter.

January 28, 2009 - FluoroPharma Inc., a molecular imaging company engaged in the discovery and development of proprietary products for the PET market, said it has received a U.S. Patent covering methods of imaging cardiovascular plaque formation using F18 labeled 2-fluorodeoxy-D-glucose (FDG).

This patent, exclusively licensed from the Massachusetts General Hospital (MGH), provides FluoroPharma with additional patent claims that cover imaging of atherosclerotic plaque inflammation and rupture.

January 28, 2008 - Wolters Kluwer Health recently said Adena Health System has selected ProVation MD for Cardiology for procedure documentation and coding.

Adena, which currently uses ProVation MD for Gastroenterology and Pulmonary procedures, will use the software to document diagnostic, interventional and peripheral vascular cases at its Adena Regional Medical Center catheterization lab in Chillicothe, OH.

January 28, 2009 - Data published this week in the online journal Circulation from the SPIRIT III U.S. pivotal trial demonstrates that the XIENCE V everolimus-eluting coronary stent system outperforms the TAXUS Express2 paclitaxel-eluting coronary stent system in reducing a patient’s likelihood of suffering a heart attack or requiring a repeat intervention out to two years.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now